pharmalittle - Robuta Search

https://www.statnews.com/pharmalot/2026/04/13/revolution-pancreatic-cancer-pill-fda-rejects-replimune-cancer-drug/ Pharmalittle: Pancreas cancer data strong, Replimune drug rejected| STAT Apr 13, 2026 - The FDA rejected — again — an experimental treatment for advanced skin cancer developed by Replimune, which has become a flashpoint. pancreas cancer drug rejected pharmalittle data strong https://www.statnews.com/pharmalot/2026/03/26/fda-rare-disease-pto-novo-nordisk-340b-abortion-hiv/ Pharmalittle: FDA approves rare disease drug, PTO chief grilled | STAT Mar 26, 2026 - A bipartisan quartet of senators unveiled legislation to cap the monthly cost of insulin at $35 for patients on private insurance. rare disease drug pharmalittle fda approves pto chief https://www.statnews.com/pharmalot/2026/04/20/pharmalittle-were-reading-about-trump-boosting-psychedelic-treatment-the-future-for-weight-loss-drugs-and-more/ Pharmalittle: We're reading about Trump boosting psychedelic treatment, the future for weight-loss... weight loss pharmalittle reading trump boosting https://www.statnews.com/pharmalot/2026/03/27/novo-nordisk-boost-consumer-focus-fda-approves-gene-therapy/ Pharmalittle: Novo boosts consumer focus, FDA okays gene therapy | STAT Mar 27, 2026 - People with pre-existing depression or anxiety were less likely to have worsening mental health while taking a GLP-1 medication. gene therapy pharmalittle novo boosts consumer https://www.statnews.com/pharmalot/2026/04/27/lilly-deal-intellia-crispr-treatment-for-rare-disease/ Pharmalittle: Lilly buying Ajax, Intellia reports HAE CRISPR results | STAT Apr 27, 2026 - A pill for hair loss successfully spurred hair growth in a late-stage trial amid a surge of investor enthusiasm for such products results stat pharmalittle lilly buying ajax https://www.statnews.com/pharmalot/2026/03/24/trump-drug-pricing-flaw-gilead-buys-ouro/ Pharmalittle: Flaw seen in Trump MFN plan, Gilead buying Ouro | STAT Mar 24, 2026 - Gilead Sciences plans to acquire Ouro Medicines, a developer of autoimmune-disease therapies, for up to about $2.18 billion. pharmalittle flaw seen trump mfn https://www.statnews.com/pharmalot/2026/04/22/medicare-obesity-drug-pilot-program-experimental-roche-ms-drug/ Pharmalittle: Medicare drops obesity drug pilot, Roche touts MS data | STAT Apr 22, 2026 - Roche presented the latest data for its experimental multiple sclerosis drug, setting the stage for the company to seek FDA approval. obesity drug pharmalittle medicare drops pilot https://www.statnews.com/pharmalot/2026/04/01/fda-compounding-peptides-iran-war-trial-recruitment/ Pharmalittle: FDA changing view on peptides; Iran war affects trials| STAT Apr 1, 2026 - Of more than 65,000 clinical trials recruiting patients in 186 countries, nearly 7% have been affected by the Iran war. iran war affects pharmalittle fda trials stat changing view https://www.statnews.com/pharmalot/2026/04/14/fda-push-clinical-trial-transparency-novo-nordisk-openai-deal/ Pharmalittle: FDA push for trial transparency, Novo-OpenAI deal | STAT Apr 14, 2026 - AstraZeneca to require hospitals and clinics participating in a U.S. drug discount program to submit claims data for dispensing its drugs pharmalittle fda trial transparency openai deal push novo https://www.statnews.com/topic/pharmalittle/ Pharmalittle: Ed Silverman on the Pharma News of the Day | STAT A STAT+ newsletter on the pharmaceutical industry by veteran Pharmalot columnist Ed Silverman. Sign up for pharma news in your inbox Monday-Friday. ed silverman pharma news pharmalittle day stat https://www.statnews.com/pharmalot/2026/04/23/telehealth-visits-pharma-withholding-new-meds-in-europe/ Pharmalittle: Drug firms offer telehealth coupons; GLP-1 pill for kids? | STAT Apr 23, 2026 - HHS Secretary Robert F. Kennedy Jr. told a Senate hearing he had nothing to do with an FDA ‌decision to not approve Replimune's cancer drug glp 1 pill pharmalittle drug firms offer https://www.statnews.com/pharmalot/2026/04/03/trump-pharma-tariffs-uk-trade-deal/ Pharmalittle: Drug tariffs imposed, U.K. reaches pharma trade deal | STAT Apr 3, 2026 - A pharmaceutical trade deal grants ‌U.K. tariff-free access for its drugs in the U.S. in return for paying higher prices for new U.S. meds. drug tariffs trade deal pharmalittle imposed k https://www.statnews.com/pharmalot/2026/04/17/lilly-weight-loss-pill-results-uk-slashing-clinical-trial-times/ Pharmalittle: Lilly releases obesity pill results, U.K. cuts trial times | STAT Apr 17, 2026 - The FDA may approve testosterone replacement therapy to treat low sex drive in men who do ‌not produce enough of the hormone. obesity pill results u pharmalittle lilly releases https://www.statnews.com/pharmalot/2026/04/15/fda-seeks-data-lilly-obesity-pill-pharma-win-340b-case-hiv/ Pharmalittle: FDA seeks Lilly obesity pill data, pharma gets 340B win | STAT Apr 15, 2026 - A Delaware judge threw out lawsuits seeking to link the Zantac heartburn drug to cancer, freeing drugmakers from facing trials in the state. pharmalittle fda obesity pill seeks lilly data https://www.statnews.com/pharmalot/2026/03/31/pharma-delays-european-launches-lilly-biogen-deals-gilead/ Pharmalittle: Pharma delays Europe launches, Lilly, Biogen deals | STAT Mar 31, 2026 - Merck said its non-statin cholesterol drug met the main goal of reducing bad cholesterol in a late-stage head-to-head trial with other drugs europe launches pharmalittle delays lilly biogen https://www.statnews.com/signup/pharmalittle/ Sign up for Pharmalittle | STAT Apr 2, 2024 - Ed Silverman's daily morning newsletter rounds up the most important news of the day in the global drug industry. sign pharmalittle stat https://www.statnews.com/pharmalot/2026/03/23/iran-war-pharma-supply-chain-pfizer-lyme-vaccine/ Pharmalittle: Iran war impact on pharma, Pfizer Lyme vaccine data | STAT Mar 23, 2026 - Roche is stopping clinical development of a drug candidate for two muscle diseases, but plans to continue evaluating it for obesity. iran war impact lyme vaccine pharmalittle pfizer data https://www.statnews.com/pharmalot/2026/04/21/purdue-pharma-settlement-setback-for-merck-and-eisai/ Pharmalittle: Purdue settlement near, Merck-Eisai cancer study fails | STAT Apr 21, 2026 - All 20 smoldering multiple myeloma patients given a CAR-T therapy in a clinical trial did not have any detectable myeloma cells in their body purdue settlement cancer study pharmalittle near merck https://www.statnews.com/pharmalot/2026/04/16/alzheimers-drugs-review-fda-panel-for-compounded-peptides/ Pharmalittle: Alzheimer's drugs reviewed, FDA panel to vet peptides | STAT Apr 16, 2026 - A new report released by Senate Democrats finds that prescription drug prices have continued to climb — in some cases, sharply. pharmalittle alzheimer drugs reviewed fda